产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
(rel)-AR234960 | A648951-50mg | ≥99% | 1408311-94-3 | 50mg | ¥ 24000.9 | 期货,请咨询 | 阿拉丁 |
(rel)-AR234960 | A648951-10mg | ≥99% | 1408311-94-3 | 10mg | ¥ 8800.9 | 期货,请咨询 | 阿拉丁 |
(rel)-AR234960 | A648951-100mg | ≥99% | 1408311-94-3 | 100mg | ¥ 35000.9 | 期货,请咨询 | 阿拉丁 |
ALK2-IN-2 | A648931-5mg | ≥99% | 2254409-25-9 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
ALK2-IN-2 | A648931-50mg | ≥99% | 2254409-25-9 | 50mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
ALK2-IN-2 | A648931-25mg | ≥99% | 2254409-25-9 | 25mg | ¥ 9900.9 | 期货,请咨询 | 阿拉丁 |
ALK2-IN-2 | A648931-10mg | ≥99% | 2254409-25-9 | 10mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
ALK2-IN-2 | A648931-100mg | ≥99% | 2254409-25-9 | 100mg | ¥ 22500.9 | 期货,请咨询 | 阿拉丁 |
Angiotensin II 5-valine | A648913-5mg | ≥99% | 58-49-1 | 5mg | ¥ 450.9 | 期货,请咨询 | 阿拉丁 |
Angiotensin II 5-valine | A648913-50mg | ≥99% | 58-49-1 | 50mg | ¥ 690.9 | 期货,请咨询 | 阿拉丁 |
Angiotensin II 5-valine | A648913-10mg | ≥99% | 58-49-1 | 10mg | ¥ 550.9 | 期货,请咨询 | 阿拉丁 |
ALS-8112 | A648901-5mg | ≥99% | 1445379-92-9 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
ALS-8112 | A648901-50mg | ≥99% | 1445379-92-9 | 50mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 |
ALS-8112 | A648901-1mg | ≥99% | 1445379-92-9 | 1mg | ¥ 1500.9 | 期货,请咨询 | 阿拉丁 |
ALS-8112 | A648901-10mg | ≥99% | 1445379-92-9 | 10mg | ¥ 5000.9 | 期货,请咨询 | 阿拉丁 |
ALS-8112 | A648901-100mg | ≥99% | 1445379-92-9 | 100mg | ¥ 21000.9 | 期货,请咨询 | 阿拉丁 |
AUT1 | A648897-5mg | ≥99% | 1311136-84-1 | 5mg | ¥ 1200.9 | 期货,请咨询 | 阿拉丁 |
AUT1 | A648897-50mg | ≥99% | 1311136-84-1 | 50mg | ¥ 5000.9 | 期货,请咨询 | 阿拉丁 |
AUT1 | A648897-10mg | ≥99% | 1311136-84-1 | 10mg | ¥ 1750.9 | 期货,请咨询 | 阿拉丁 |
AUT1 | A648897-100mg | ≥99% | 1311136-84-1 | 100mg | ¥ 8000.9 | 期货,请咨询 | 阿拉丁 |
ABN401 | A648892-5mg | ≥96% | 2242563-15-9 | 5mg | ¥ 6500.9 | 期货,请咨询 | 阿拉丁 |
ABN401 | A648892-10mg | ≥96% | 2242563-15-9 | 10mg | ¥ 10500.9 | 期货,请咨询 | 阿拉丁 |
AES-350 | A648886-5mg | ≥98% | 847249-57-4 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
AES-350 | A648886-25mg | ≥98% | 847249-57-4 | 25mg | ¥ 11000.9 | 期货,请咨询 | 阿拉丁 |